Noluthando Mwelase
University of the Witwatersrand(ZA)Helen Joseph Hospital(ZA)
Publications by Year
Research Areas
HIV/AIDS Research and Interventions, Pneumocystis jirovecii pneumonia detection and treatment, HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV-related health complications and treatments
Most-Cited Works
- → One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis(2019)362 cited
- → Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial(2019)108 cited
- → Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial(2020)88 cited
- → Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study(2017)40 cited
- → Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial(2018)36 cited
- → As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial(2018)35 cited
- → Change in Vitamin D Levels Occurs Early after Antiretroviral Therapy Initiation and Depends on Treatment Regimen in Resource-Limited Settings(2014)32 cited
- → Virologic outcomes in early antiretroviral treatment: HPTN 052(2017)31 cited
- → C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings(2015)26 cited
- → Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation(2015)23 cited